Start your Trading & Investing Journey with us
Join our channel for Daily Free Trades with Live analysis on Youtube, Trade Setup with Important Levels, and Important Stock Market Updates
Sai Life Sciences IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details
Financial Information of Sai Life Sciences Limited IPO
The revenues from operations for Fiscals ended 2024, 2023 and 2022 were ₹14,942.69 Million, ₹12,451.05 Million and ₹8,977.41 Million respectively. The EBITDA for Fiscals ended 2024, 2023 and 2022 were ₹2,881.55 Million, ₹1,864.78 Million, and ₹1,459.58 Million, respectively. The profit after tax for Fiscals ended 2024, 2023 and 2022 were ₹828.09 Million, ₹99.89 Million, and ₹62.26 Million respectively.
Sai Life Sciences Limited Financial Information (Restated Consolidated)
Amount in (₹ in Million)
| Period Ended | Mar 31, 2024 | Mar 31, 2023 | Mar 31, 2022 |
|---|---|---|---|
| Reserve of Surplus | 9,570.94 | 8,700.83 | 8,606.22 |
| Total Assets | 22,751.36 | 21,866.48 | 21,642.30 |
| Total Borrowings | 7,101.63 | 6,992.29 | 7,513.18 |
| Fixed Assets | 9,263.55 | 7,776.15 | 7,429.03 |
| Cash | 236.57 | 699.12 | 1,159.39 |
| Cash flow from operating activities | |||
| Cash flows from investing activities | |||
| Cash flow from financing activities | |||
| Net Borrowing | 6,865.06 | 6,293.17 | 6,353.79 |
| Revenue | 14,942.69 | 12,451.05 | 8,977.41 |
| EBITDA | 2,881.55 | 1,864.78 | 1,459.58 |
| PAT | 828.09 | 99.89 | 62.26 |
| PAT Margin | |||
| EPS | 4.53 | 0.55 | 0.34 |
Note 1:- RoE & ROCE calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 2:- Pre EPS and Post EPS calculation in KPI is based (Profit for the Year) on 31st Mar, 2024 Data, given in RHP.
Note 3:- RoNW calculation in KPI is based on 31st Mar, 2024 Data, given in RHP.
Note 4:- Price to Book Value calculation in KPI is based on Cap Price after Completion of the Offer, given in FINANCIAL EXPRESS.
© 2022 CA Abhay Varn. All Rights Reserved Abhayvarn.com
